The Nasdaq Biotechnology Index rose by 1.29%. Among the constituent stocks, CG Oncology increased by 24.99%, UroGen Pharma rose by 14.08%, and ADMA Biologics climbed by 12.03%. In contrast, Neurogene fell by 5.91%, Amylyx Pharmaceuticals dropped by 6.53%, and Q32 Bio decreased by 9.89%
The Nasdaq Biotechnology Index closed up 1.29%.
Component stock CG Oncology rose 24.99%, UroGen Pharma increased by 14.08%, and ADMA Biologics was up 12.03%, ranking third.
Neurogene fell 5.91%, ranking third from the bottom, Amylyx Pharmaceuticals dropped 6.53%, and Q32 Bio decreased by 9.89%